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Abstract 
The unicellular green alga Chlamydomonas reinhardtii has potential as a cell factory for the 
production of recombinant proteins and other novel compounds, but mainstream adoption 
has been hindered by a scarcity of genetic tools and a need to identify products that can be 
generated in a cost-effective manner. A promising strategy is to use algal chloroplasts as a 
site for synthesis of high value bioactive compounds such as diterpenoids since these are 
derived from metabolic building blocks that occur naturally within the organelle. However, 
synthesis of these complex plant metabolites requires the introduction of membrane-
associated enzymes including cytochrome P450 enzymes (P450s). Here, we show that a 
gene (CYP79A1) encoding a model P450 can be introduced into the C. reinhardtii 
chloroplast genome using a simple transformation system. The gene is stably expressed 
and the P450 is efficiently targeted into chloroplast membranes, where it is active and 
accounts for 0.4% of total cell protein. These results provide proof of concept for the 
introduction of diterpenoid synthesis pathways into the chloroplast of Chlamydomonas 
reinhardtii. 
 
Keywords:  Chlamydomonas, chloroplast transformation, cytochrome P450, diterpenoids, 
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1. Introduction 
The green alga Chlamydomonas reinhardtii has served as an important model organism for 
studies on photosynthesis, chloroplast biology and cell physiology. However, this freshwater 
alga has also evoked interest as a production platform for recombinant proteins and other 
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products; heterologous genes can be expressed in both the nuclear and chloroplast 
genomes (Purton et al., 2013; Rasala et al., 2014), and the organism grows rapidly and is 
relatively inexpensive to culture. These factors raise the possibility that cultures can be 
grown in large-scale photobioreactors, which significantly reduces the risk of contamination 
and the escape of genetic modified strains to the environment, and makes rapid scale-up 
possible. In addition, green algae fall into the GRAS (generally regarded as safe) category, 
potentially eliminating some downstream processing steps associated with transgenically 
produced therapeutics (Rasala and Mayfield, 2011; Specht et al., 2010). 
 
The chloroplast of C. reinhardtii has been a preferred site for the expression of commercially 
attractive products since it offers a number of advantages compared to the transformation of 
the nuclear genome. In the chloroplast, high gene expression levels can be achieved and it 
is possible to target transgenes to defined sites using homologous recombination. In 
contrast, genes introduced into the nuclear genome integrate randomly and are therefore 
prone to position effects and RNA silencing. (Day and Goldschmidt-Clermont, 2011). 
 
In recent years several advances have been made in the field of Chlamydomonas 
chloroplast transformation (Purton et al. 2013). Nevertheless, most transformation protocols 
still rely on antibiotic resistance for selection. A commonly used selectable marker is the 
aadA gene (bacterial aminoglycoside 3’’-adenyl transferase), which confers resistance to 
spectinomycin and streptomycin (Goldschmidt-Clermont, 1991). Alternatively, cloned 
variants of the endogenous ribosomal RNA genes rrnS and rrnL can be used as markers. 
These carry point mutations rendering the ribosomes insensitive to certain damaging 
antibiotics (Newman et al., 1990). However, such antibiotic selection is prone to high rates of 
false positives, and in the latter case results in a mutant ribosome in which translation of a 
highly expressed transgene is potentially compromised. Furthermore, ensuring that 
transgenic lines are homoplasmic (i.e. that all ~80 copies of the polyploid chloroplast 
genome carry the introduced transgene) requires multiple rounds of single colony isolation 
under antibiotic selection. A more elegant method is to rely on the restoration of 
photosynthetic growth using a Chlamydomonas chloroplast mutant defective in an essential 
photosynthesis gene such as atpB, or psbH (Boynton et al., 1998;  Economou et al. 2014). 
Importantly, the gene of interest remains the only segment of foreign DNA in the transformed 
genome. A similar strategy has been described earlier by Cheng et al. (2005).  
 
To-date, over 50 different recombinant proteins have been synthesized successfully in the 
C. reinhardtii chloroplast, including markers, reporters, enzymes, and proteins of therapeutic 
value such as antibodies, hormones and vaccines (Purton 2013). A fully functional human 
IgG1 monoclonal antibody against anthrax protective antigen 83 was expressed from two 
separate genes and assembled into a fully active antibody (Tran et al., 2009). In addition, 
immunotoxins for cancer therapeutics (Tran et al., 2013) as well as vaccine candidates 
against malaria or foot-and-mouth-disease virus have been produced in the chloroplast 
(Gregory et al., 2013; Jones et al., 2013). However, most of the recombinant proteins 
produced, have been soluble proteins, and furthermore have generally been proteins that 
can be considered ‘benign’ in that they have no effect on chloroplast metabolism. To-date 
there has been only a few reported attempts to express membrane-associated proteins, or 
enzymes that introduce novel metabolic pathways (Blatti et al., 2012; Wu et al., 2010). 
 
As a consequence, C. reinhardtii has yet to compete effectively with other, heterotrophic 
production hosts for the production of recombinant biopharmaceuticals. Here, we have taken 
the approach that algae may be preferentially suited for the production of plant-specific 
compounds. One such class of compounds is terpenoids. These are large, structurally-
complex plant metabolites that include a range of very high-value examples including 
paclitaxel, artemisinin and ingenol-3-angelate (Wang, 2005).  Importantly, their complex 
structures almost invariably mean that efficient chemical synthesis is extremely difficult, and 
usually impossible. In principle, it should be possible to introduce novel terpenoid 
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biosynthesis pathways into the plant or algal chloroplast, but this would require re-targeting 
of the key enzymes in their synthesis, cytochromes P450, into the chloroplasts in an active 
form. Nielsen et al (2013) have reported the successful synthesis of Dhurrin in tobacco 
chloroplasts and showed that synthesis is light-driven using native ferredoxin as the electron 
donor. Dhurrin is a plant defense compound found in Sorghum bicolor. While Dhurrin is not a 
terpenoid, it is synthesized from tyrosine by the means of three ER localized cytochrome 
P450 enzymes, CYP79A1 (Sibbesen et al., 1995), CYP71E1 (Kahn et al., 1997) and POR 
(NADPH cytochrome P450 oxidoreductase), as well as the soluble cytosolic UDP glucosyl 
transferase UGT85B1 (Jones et al., 1999). 
 
As a first step in introducing in such a pathway into a phototrophic microorganism suitable 
for industrial cultivation (Specht et al. 2010), we report the stable expression of the 
cytochrome P450 CYP79A1 in the chloroplast of C. reinhardtii using a simple transformation 
method that results in a transgenic line with the CYP79A1 synthetic gene as the only foreign 
DNA. The enzyme is targeted into the organelle membrane, accumulates to ~0.4% of total 
cellular protein and is shown to be active in the conversion of tyrosine to p-
hydroxyphenylacetaldoxime. The work paves the way for the introduction of additional 
components of the Dhurrin pathway. 
 
2. Results and Discussion 
2.1 Transformation strategy and construction of the chloroplast expression vector 
The overall strategy for this study is shown in Figure 1. In the ER, P450s are located in the 
ER membrane by means of an N-terminal transmembrane span; they drive reactions using 
reducing power from NADPH but the immediate electron donor is cytochrome P450 
reductase (POR). In this study the aim was to express a model P450, CYP79A1, in C. 
reinhardtii chloroplasts, target the enzyme to the thylakoid membrane and drive the reaction 
using reduced ferredoxin (Fd). This has been shown to be possible in transiently transfected 
tobacco chloroplasts (Nielsen et al., 2013) and our aim was to determine whether algal 
chloroplasts are a viable production base for stable expression of these enzymes. 
 
A recently-developed method for chloroplast transformation (Economou et al., 2014)  uses a 
C. reinhardtii strain in which the chloroplast psbH gene has been replaced by the aadA 
antibiotic resistance cassette. The vector pASapI is used to introduce the gene of interest 
and restore photosynthetic growth. The expression cassette of pASapI is comprised of the 
promoter, the 5’ UTR and the start codon of atpA, a multiple cloning site, and the stop codon 
and 3’UTR of rbcL. Upon homologous recombination the aadA cassette is replaced with 
both a functional copy of psbH and the gene of interest (in this case the coding sequence for 
CYP79A1; see Figure 2). Importantly, the gene of interest remains the only segment of 
foreign DNA in the transformed genome.  
 
The CYP79A1 coding sequence was synthesized de novo, incorporating the coding 
sequence for a C-terminal HA tag to facilitate identification and analysis. The synthesized 
CYP79A1 construct was cloned into pASapI as indicated in Figure 2, and C. reinhardtii 
chloroplast transformation was performed by rapid agitation of a DNA/cell mixture with glass 
beads and selection for photoautotrophic growth. After approximately four weeks 
transformant colonies were obtained and subjected to further analysis. Control 
transformations, performed without the addition of DNA, did not yield any colonies. 
 
2.2  Integration of the CYP79A1 construct into the chloroplast genome 
Correct integration of the CYP79A1 gene into the chloroplast genome was confirmed using a 
PCR approach. Primers were designed to amplify a 1200 bp fragment from transformed 
lines (containing an intact restored psbH gene). Figure 3 shows a PCR analysis of the 
transgenic line (CYP79A1) with the 1200 bp clearly visible; control PCR reactions using 
primers for the disrupted psbH gene confirmed the homoplasmic integration of the CYP79A1 
construct into the chloroplast of C. reinhardtii.  
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2.3  Accumulation and localisation of the recombinant CYP79A1 protein in the chloroplast 
The expression of CYP79A1 was tested by immunoblotting of C. reinhardtii samples using 
antibodies to the HA tag as shown in Figure 4. A clear protein signal of 58 kDa, close to the 
expected size of CYP79A1 (62 kDa) was detected in samples from transgenic cells 
(CYP79A1 lane) but not in samples from the restored wild type (TN72-RP). The anti-HA 
antibody also detects a smaller polypeptide, but this is also present in control samples 
indicating a non-specific reaction (band is denoted n.s.).  
 
To estimate the amount of protein expressed in the chloroplast of Chlamydomonas we used 
a HA-tagged reference protein, HA-Ubiquitin. Figure 4 shows the signals obtained with 
increasing loadings of this protein and densitometric analysis of calibrated immunoblots 
revealed an accumulation of approximately 900 ng of protein per ml of culture. We 
calculated that the expressed CYP79A1 corresponds to 0.4% of total cell protein. 
 
Since CYP79A1 is a membrane-bound enzyme in its natural environment (the plant ER) we 
investigated its location in algal cells to confirm membrane targeting and insertion. TN72-RP 
and CYP79A1 cells were lysed by sonication and the soluble and insoluble fractions were 
separated by ultracentrifugation. Immunoblotting shows that CYP79A1 signal is almost 
exclusively detected in the membrane fraction of the transgenic cell line. As a control for the 
pelleting of thylakoids membranes, we confirmed that essentially all of the chlorophyll (over 
98%) was pelleted by this procedure (data not shown). (Figure 5). These data show that the 
CYP79A1 protein is efficiently targeted into membranes during or after synthesis in the 
chloroplast. The data also show that the band generated by non-specific reaction with the 
antibody (n.s.) is present in the soluble fraction.  
 
2.4  Enzymatic activity of CYP79A1 
CYP79A1 is the first enzyme in the dhurrin synthesis pathway and it converts tyrosine to p-
hydroxyphenylacetaldoxime. To test whether the enzyme is active in the Chlamydomonas 
transformant chloroplasts, we subjected samples of the transgenic strain and restored wild 
type to LC-MS analysis. A comparison of the mass spectrum to that of an oxime standard 
revealed that the enzyme is active in the CYP79A1 transformant (Figure 6); as expected, the 
restored wild type sample does not exhibit any oxime-related peaks. Interestingly, the oxime 
was detected in the culture medium of unlysed transformant cells, but was absent in extracts 
of both the soluble or insoluble fractions after sonication. This shows that the oxime reaction 
product is able to exit the cells, presumably by diffusion since the cells are unlikely to contain 
an efflux system for this compound. The much smaller volume of the cells (compared to the 
culture medium) probably explains why the product is not detected in those samples. 
 
3.  Concluding remarks 
Cytochrome P450 monooxygenases catalyze key reactions in the biosynthetic pathways of 
many complex natural products including terpenoids. They are normally located in the 
endoplasmic reticulum by means of N-terminal transmembrane spans (Frear et al., 1969; 
Zhao et al., 2014). However, these NADPH requiring pathways usually proceed inefficiently, 
and plants additionally contain numerous other P450s (typically around 300, although not all 
are expressed at the same time) . A given P450 is usually present at relatively low levels, 
and, in general, In general, any single P450-dependent pathway usually catalyses low-level 
synthesis of a given product. It is therefore highly attractive to relocate the cytochrome 
P450-dependent steps from the ER to the chloroplast of C. reinhardtii; the key P450s may 
then be present in higher amounts and able to use reducing power supplied by 
photosynthesis to drive their reactions. In this proof of concept study we have tested whether 
CYP79A1, the first enzyme in the biosynthetic pathway of dhurrin, can be expressed in the 
chloroplast membranes of C. reinhardtii in an active form. CYP79A1 was chosen because it 
is easily assayed and has been transiently expressed in tobacco and targeted to the 
chloroplast (Nielsen et al., 2013). The enzyme has also been expressed in cyanobacteria 
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(Lassen et al, 2014). The results show that the enzyme is indeed expressed, targeted into 
membranes and active. The protein levels (0.4% of total protein) are sufficiently high to 
readily detect enzymatic activity, the reaction product being detectable in the culture medium 
where it is relatively dilute.  
 
There are good reasons to believe that the CYP79A1 is driven directly by reducing power 
supplied by photosynthesis. P450s do not oxidise NADPH themselves, and in the ER, they 
are driven by a set of specific enzymes termed NADPH cytochrome P450 oxidoreductase, 
which transfer reducing power from NADPH.. When CYP79A1 was expressed transiently in 
tobacco chloroplasts, it was shown to use electrons from photosynthetically reduced 
ferredoxin (Fd) (Nielsen et al., 2013). It is therefore assumed that the algal-expressed 
CYP79A1 in this study is similarly driven by reduced Fd, but we should emphasise that this 
has not been shown directly. The highly negative redox potential of ferredoxin and its high 
abundance raises the possibility that the cytochrome P450 may work very efficiently in the 
chloroplast, but we have not compared the specific activities of the ER- and plastid-localised 
forms and this will be a prioirty for future studies. 
 
While the primary aim of this study was to test the feasibility of expressing cytochrome P450 
enzymes in algal chloroplasts, the results have relevance for the wider field of microalgal 
biotechnology. To date, chloroplast transformation of Chlamydomonas reinhardtii has been 
used to express soluble proteins such as antibodies or vaccine candidates (Demurtas et al., 
2013; Tran et al., 2009), but to our knowledge no membrane-bound protein has been 
expressed in an active form. Moreover, there are reasons to consider that this may be 
intrinsically difficult to achieve; the thylakoid and envelope membranes differ radically in lipid 
composition when compared to other membranes (ca. 80% galactolipids, whereas the ER is 
primarily composed of phospholipids). In addition, we assume that the CYP79A1 is targeted 
into the thylakoid membranewhich accounts for the vast majority of chloroplast membrane 
surface area (although some CYP79A1 may be targeted to the envelope membranes), and 
proteins are targeted into this membrane by mechanisms that differ in fundamental respects 
from those used for insertion of proteins into other membranes, including the ER (Woolhead 
et al., 2001). It was therefore important to confirm that an ER membrane protein can be 
targeted into chloroplast membranes at reasonably high levels, in an active form. 
 
To summarise, we here show the first expression of an active, membrane-bound 
cytochrome P450 in the chloroplast of Chlamydomonas reinhardtii. A simple chloroplast 
transformation method and selection strategy was used to create a transformant strain that 
lacks any antibiotic resistance markers. The enzyme almost certainly uses reducing power 
from photosynthesis to drive the conversion of endogenous tyrosine to an oxime that 
appears to diffuse from the cell into the medium. This study thus represents a first step in the 
proof-of-concept for the production of diterpenoids in the Chlamydomonas chloroplast.  
 
4.  Experimental  
Chlamydomonas cultures 
Strains were grown in acetate-containing (TAP) medium or minimal (HSM) medium as 
described in (Harris et al., 2009), however a revised trace metal recipe was used as found in 
(Kropat et al., 2011). Cells were grown in 100 ml cultures, at 25°C, shaking at 110 rpm using 
illumination at 15 µmol photons m-2s-1.   
 
Plasmid design 
The pASapI vector, described in (Economou et al., 2014), was used for the introduction of 
the CYP79A1 coding sequence into the chloroplast genome. The CYP79A1 amino acid 
sequence (accession number XP_002466099) was codon optimized using the Codon Usage 
Optimizer (http://codonusageoptimizer.org/download/) with codon frequency-, pair- and 
weight tables of highly expressed chloroplast genes handpicked by the developer. The 
optimized sequence was synthesized using GenScript (Piscataway, USA). The gene was 
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cloned into pASapI using the restriction enzymes SapI and SphI (New England Biolabs) to 
create pASapI-CYP79. 
 
Chloroplast transformation 
Chloroplast transformation of C. reinhardtii was based on a previously described method 
(Kindle and Sodeinde, 1994; Kindle, 1990) and involved the agitation of an algal/DNA 
suspension with glass beads of 400-625 µm diameter (Sigma, St Louis, USA). A 400 ml 
culture grown to early log phase (approx. 2 x106 cells/ml) was concentrated by centrifugation 
and resuspended in TAP to 4 ml. 300 µl of these cells (at approx. 2 x 108 cells/ml) was 
added to a sterilised 5 ml test tube containing 300 mg sterile glass beads, followed by 5-10 
µg circular plasmid DNA (either pASapI-CYP or the empty pASapI vector as a control). The 
mixture was agitated vigorously at the maximum speed of a Vortex Genie II (Fisher, 
Loughborough, UK) for 15 sec. The cells were spread on HSM selective agar plates after 
mixing with 0.5% molten (42oC) agar of the same selective medium. The plates were 
incubated at 25oC covered with tissue paper (~20 µmol photons m-2s-1) overnight then 
transferred to a moderate light (~50 µmol photons m-2s-1) the next day. Transformant 
colonies were picked after approximately 4 weeks and restreaked from single colonies three 
times on selective medium to ensure homoplasmicity. The transgenic lines were subjected 
to PCR analysis to confirm correct integration of the transgene (principle described in 
Economou et al. 2014). A representative line was chosen and termed TN72-CYP79A1, 
together with a pASapI transformant as a negative control (= TN72-RP). 
 
Cell disruption 
Culture cell pellets were resuspended in sonication buffer (10 mM Tris-HCl pH8, 5 mM 
MgCl2) and lysed by sonication. The membrane and soluble fractions were separated by 
ultracentrifugation (70000 rpm, 1h, 4°C, TL-100 ultracentrifuge, Beckman, Pasadena, USA).  
 
SDS-PAGE and Immunoblotting 
Total chlorophyll content of cultures was determined by extracting chlorophyll with 80% 
acetone and measuring absorbance at 645 and 663 nm (Arnon, 1949). An amount of culture 
equivalent to 5 µg chlorophyll was separated by SDS-PAGE (15% acrylamide) at 40 mA 
using a Bio-Rad Mini-PROTEAN® Tetra cell system. Proteins were blotted onto PVDF 
(BioTrace™, Pall Corporation, Port Washington, USA) membranes using a Bio-Rad Mini-
PROTEAN® Tetra cell system according to manufacturer’s instructions. The membranes 
were blocked overnight with 5% skimmed milk powder (Thermo Scientific, Waltham, USA) in 
PBS (Formedium, Norfolk, UK) + 0.01% Tween-20 (Sigma, St Louis, USA) (PBS-T) at 4°C, 
washed with PBS-T and incubated with anti-HA primary (Sigma, St Louis, USA) antibody at 
a concentration of 1:1000 in PBS-T shaking for 1hr at room temperature. After PBS-T 
washes they were incubated with an HRP coupled secondary anti-rabbit antibody (1:5000 in 
PBS-T, Promega) for 1 hour shaking at room temperature. The membranes were washed 
once again and visualised by enhanced chemiluminescence (Clarity Western ECL 
Substrate, Bio-Rad) according to manufacturer’s instructions.  The chemiluminescent signal 
was recorded using a Bio-Rad ChemiDoc XRS+ system. The exposure time was set to 2 
minutes with pictures being taken every 4 seconds. The marker was recorded and overlaid 
with a selected blot image. 
 
Protein determination 
Protein determination was performed using the Bio-Rad DC Protein assay according to 
manufacturer’s instructions. Following cell lysis by sonication and ultracentrifugation, the 
soluble fraction was taken directly for protein determination. The membrane fraction was first 
solubilized in 50 mM Tris-acetate pH 8.2, 2.5 mM EDTA pH 8 and 1% (w/v) SDS and then 
subjected to the assay. 
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Oxime-extraction and LC-MS analysis 
Broken cells were mixed in equal amounts with ethyl acetate and shaken for 5 minutes. The 
samples were then centrifuged at 10000 x g for 10 minutes, the supernatant was collected 
and evaporated completely. Media samples were mixed 3:1 with ethyl acetate and shaken 
for 1 hour. After centrifugation the upper phase was collected and evaporated.  The dried 
samples were resuspended in 80% MeOH, diluted 4 times with water and subjected to 
Liquid chromatography–mass spectrometry analysis as described in (Saito et al., 2012). The 
analysis was carried out using an Agilent 1100 Series LC (Agilent Technologies, Germany) 
coupled to a Bruker HCT-Ultra ion trap mass spectrometer (Bruker Daltonics, Bremen, 
Germany). A Zorbax SB-Aq column (Agilent; 3.5 µM, 2.1×150 mm) was used at a flow rate 
of 0.2 mL min−1. The oven temperature was maintained at 35°C. The mobile phases were: 
A, 2 mM ammonium acetate; B, methanol. The gradient program was: 0 to 1 min, isocratic 
25% B; 1 to 11 min, linear gradient 25 to 60% B; 11 to 12 min, isocratic 98% B; 12 to 20 min, 
isocratic 25% B. The mass spectrometer was run in positive APCI mode and the recorded 
mass range was m/z 80-350. 
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Figure legends 
 
Figure 1. Strategy for driving cytochrome P450 activity by photosynthetic electron 
transport. Left: normal action of P450s. Typical P450s have an N-terminal transmembrane 
span that anchors the protein in the ER membrane. Reducing power is provided by NADPH 
via NADPH-cytochrome P450 oxido-reductases (NADPH-P450 ox-red). Right: strategy for 
driving activity by photosynthetic electron transport: the P450 is synthesised in the 
chloroplast, targeted into the thylakoid membrane and reducing power is provided by 
Photosystem I (PSI) via ferredoxin (Fd).  
 
Figure 2. Chloroplast transformation strategy. A: the vector pASapI uses the essential 
photosynthesis gene psbH as a selection marker for the targeted integration of a gene of 
interest (in this case CYP79A1) into the chloroplast genome. The expression cassette is 
located in the psbH-trnE2 intergenic region and contains the promoter, 5’ untranslated 
region and start codon of atpA, a multiple cloning site and the stop codon as well as the 3’ 
untranslated region of rbcL. An aadA cassette replaces psbH in the recipient strain rendering 
it unable to grow on minimal medium lacking acetate. After transformation a functional copy 
of psbH together with the GOI is introduced back into the genome by homologous 
recombination. B: pASapI vector design. The pASapI vector was constructed using pUC8 
as a backbone. It contains psbH flanking elements, the promoter and 5’ untranslated region 
(UTR) of atpA, a polylinker with SapI and SphI sites to introduce the gene of interest and the 
3’ UTR of rbcL (Economou et al., 2014).  
 
Figure 3. Integration of the CYP79A1 construct. Genomic DNA was isolated 
from transformed cultures (CYP79A1) and subjected to PCR analysis to test for integration 
of the CYP79A1 construct. As a control the same was done with untransformed cells (TN72 
psbH-) and restored wild type cultures (TN72-RP). The Figure shows the presence of a 1200 
bp band in the transgenic lines, which confirms the integration of the expression cassette 
into the chloroplast genome. Untransformed cells produce a PCR product of 850 bp length. 
 
Figure 4. CYP79A1 is expressed in the chloroplast of C. reinhardtii. Total cell protein 
samples of restored wild type (TN72-RP) and transformant strains (CYP79A1) were 
 10 
separated using SDS-PAGE and subjected to immunoblot analysis using an anti-HA 
antibody. Known amounts of a reference protein (HA-ubiquitin) were loaded on the same 
gel. CYP79A1 band is indicated; 'n.s.' denotes non-specific cross-reacting band found in 
both cultures; HA-Ub denotes HA-Ubiquitin. 
 
Figure 5. Membrane targeting of CYP79A1. Cells of the CYP79A1 transformant and 
restored wild type (TN72-RP) cultures were lysed by sonication and the membrane (M) and 
soluble (S) fractions were separated by ultracentrifugation. Total protein in the fractions was 
subjected to SDS-PAGE and immunoblotting with an antibody against the HA-tag. The band 
corresponding to CYP79A1 is found in the membrane fraction of the transgenic line 
confirming that CYP79A1 is targeted into the membranes of C. reinhardtii. A non-specific 
cross-reacting band is denoted by n.s. 
 
Figure 6. Expressed CYP79A1 is active. The product of CYP79A1, p-
hydroxyphenylacetaldoxime, was extracted from the culture medium of CYP79A1 
transformant or restored wild type cultures with ethyl acetate after pelleting the cells by 
centrifugation. The samples were analysed by liquid chromatography–mass spectrometry 
and compared to an oxime standard as described in the Experimental section.  
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